CBMG

Cellular Biomedicine Group, Inc.
CBMG

Delisted

CBMG was delisted on the 19th of February, 2021.

Back to rankings

43 hedge funds and large institutions have $71.7M invested in Cellular Biomedicine Group, Inc. in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$201K
Puts
$317K
Net Calls
Net Calls Change

Top Buyers

1
+$1.04M
2
+$546K
3
+$355K
4
Two Sigma Investments
Two Sigma Investments
New York
+$350K
5
JP Morgan Chase
JP Morgan Chase
New York
+$310K

Top Sellers

1
-$416K
2
-$416K
3
-$99.4K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$34.1K
5
TRCT
Tower Research Capital (TRC)
New York
-$17.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$157K
27
$123K
28
$94K
29
$80K
30
$68K
31
$52K
32
$43K
33
$42K
34
$39K
35
$33.9K
36
$25K
37
$16K
38
$14K
39
$2K
40
$2K
41
$2K
42
$195
43
–
1
2